Colorectal carcinoma screening: Established methods and emerging technology

References

• Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–117.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
   Google Scholar
• Moore HG. Colorectal cancer: what should patients and families be told to lower the risk of colorectal cancer? Surg Oncol Clin N Am. 2010;19(4):693–710.
   PubMed Web of Science ®Google Scholar
• Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54.
   PubMed Web of Science ®Google Scholar
• Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290(22):2959–2967.
   PubMed Web of Science ®Google Scholar
• Botteri E, Iodice S, Raimondi S, et al. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008;134(2):388–395.
   PubMed Web of Science ®Google Scholar
• Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One 2013;8(1):e53916.
   PubMed Web of Science ®Google Scholar
• Samadder NJ, Curtin K, Tuohy TM, et al. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology. 2014;147(4):814–816.
   PubMed Web of Science ®Google Scholar
• Lowery JT, Ahnen DJ, Schroy PC, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer. 2016;122(17):2633–2645.
   PubMed Web of Science ®Google Scholar
• Jasperson KW, Tuohy TM, Neklason DW, et al. Hereditary and familial colon cancer. Gastroenterology. 2010;138(6):2044–2058.
   PubMed Web of Science ®Google Scholar
• Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348(10):919–932.
   PubMed Web of Science ®Google Scholar
• Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50(1):113–130.
   PubMed Web of Science ®Google Scholar
• Brenner H, Altenhofen L, Stock C, et al. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2013;22(6):1043–1051.
   PubMed Web of Science ®Google Scholar
• Beerenwinkel N, Antal T, Dingli D, et al. Genetic progression and the waiting time to cancer. PLoS Comput Biol. 2007;3(11):e225.
   PubMed Web of Science ®Google Scholar
• Winawer SJ. The history of colorectal cancer screening: a personal perspective. Dig Dis Sci. 2015;60(3):596–608.
   PubMed Web of Science ®Google Scholar
• Eddy D. Guidelines for the cancer-related checkup: recommendations and rationale. Ca-A. Cancer J. Clin. 1980;30(4):194–240.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–193.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J Natl Cancer Inst. 2017;109(8). Available from: https://www.ncbi.nlm.nih.gov/pubmed/28376186
   Google Scholar
• White A, Thompson TD, White MC, et al. Cancer screening test use — United States. MMWR Morb Mortal Wkly Rep. 2017;66(8):201–206.
   PubMed Web of Science ®Google Scholar
• Goldberg DW, Kohler B, Kosary C. The Texas H&M, NAACCR. NCI Geocoding Service. 2016 [cited 2019 Apr 15]. Available from: https://www.naaccr.org/
   Google Scholar
• Wolf RL, Basch CE, Brouse CH, et al. Patient preferences and adherence to colorectal cancer screening in an urban population. Am J Public Health. 2006;96(5):809–811.
   PubMed Web of Science ®Google Scholar
• Zavoral M, Suchanek S, Zavada F, et al. Colorectal cancer screening in Europe. WJG. 2009;15(47):5907–5915.
   PubMed Web of Science ®Google Scholar
• Cenin DR, St John DJ, Ledger MJ, et al. Optimising the expansion of the National Bowel Cancer Screening program. Med J Aust. 2014;201(8):456–461.
   PubMed Web of Science ®Google Scholar
• Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–767.
   PubMed Web of Science ®Google Scholar
• Müller MF, Ibrahim AEK, Arends MJ. Molecular pathological classification of colorectal cancer. Virchows Arch. 2016;469(2):125–134.
   PubMed Web of Science ®Google Scholar
• Carethers JM, Jung BH. Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology. 2015;149(5):1177–1190.e3.
   PubMed Web of Science ®Google Scholar
• Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348(apr09 1):g2467.
   PubMedGoogle Scholar
• Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106–1114.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: updated evidence report and systematic review for the us preventive services task force. JAMA. 2016;315(23):2576–2594.
   PubMed Web of Science ®Google Scholar
• Patel SS, Kilgore ML. Cost effectiveness of colorectal cancer screening strategies. Cancer Control. 2015;22(2):248–258.
   PubMed Web of Science ®Google Scholar
• Hanly P, Skally M, Fenlon H, et al. Cost-effectiveness of computed tomography colonography in colorectal cancer screening: a systematic review. Int J Technol Assess Health Care. 2012;28(4):415–423.
   PubMed Web of Science ®Google Scholar
• Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33(1):88–100.
   PubMed Web of Science ®Google Scholar
• Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104(3):739–750.
   PubMed Web of Science ®Google Scholar
• Navarro M, Nicolas A, Ferrandez A, et al. Colorectal cancer population screening programs worldwide in 2016: an update. WJG. 2017;23(20):3632–3642.
   PubMed Web of Science ®Google Scholar
• Leddin D, Lieberman DA, Tse F, et al. Clinical practice guideline on screening for colorectal cancer in individuals with a family history of nonhereditary colorectal cancer or adenoma: the Canadian Association of Gastroenterology Banff Consensus. Gastroenterology. 2018;155(5):1325.e3–1347.e3.
   Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. (eds). SEER cancer statistics review 1975–2013 National Cancer Institute SEER Cancer statistics review 1975–2013 National Cancer Institute. SEER Cancer Stat. Rev. 1975–2013. Bethesda (MD): National Cancer Institute. Available from: https://seer.cancer.gov/csr/1975_2013/, based November 2015 SEER data submission, posted to SEER web site, April 2016.
   Google Scholar
• Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Gastroenterology. 2017;153(1):307–323.
   PubMed Web of Science ®Google Scholar
• Kelly JJ, Alberts SR, Sacco F, et al. Colorectal cancer in Alaska native people, 2005–2009. Gastrointest Cancer Res. 2012;5:149–154.
   PubMedGoogle Scholar
• Kelly JJ, Lanier AP, Schade T, et al. Cancer disparities among Alaska native people, 1970-2011. Prev Chronic Dis. 2014;11:E221.
   Web of Science ®Google Scholar
• Zauber A, Knudsen A, Rutter CM, et al. Evaluating the benefits and harms of colorectal cancer screening strategies: a collaborative modeling approach. AHRQ. 2015.
   Google Scholar
• Koretz RL, Lin JS. Evidence-based guideline: the USPSTF recommends screening for colorectal cancer in adults 50 to 75 years of age. Ann Intern Med. 2016;165(6):JC26.
   Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–2575.
   PubMed Web of Science ®Google Scholar
• van Hees F, Habbema JD, Meester RG, et al. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med. 2014;160(11):750–759.
   PubMed Web of Science ®Google Scholar
• Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–1477.
   PubMed Web of Science ®Google Scholar
• Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365–1371.
   PubMed Web of Science ®Google Scholar
• Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467–1471.
   PubMed Web of Science ®Google Scholar
• Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603–1607.
   PubMed Web of Science ®Google Scholar
• Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterology. 2008;103(6):1541–1549.
   PubMed Web of Science ®Google Scholar
• Shapiro JA, Bobo JK, Church TR, et al. A comparison of fecal immunochemical and high-sensitivity guaiac tests for colorectal cancer screening. Am J Gastroenterol. 2017;112(11):1728–1735.
   PubMed Web of Science ®Google Scholar
• Young GP, Symonds EL, Allison JE, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60(3):609–622.
   PubMed Web of Science ®Google Scholar
• Songster CL, Barrows GH, Jarrett DD. Immunochemical detection of fecal occult blood–the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer. 1980;45(S5):1099–1102.
   PubMedGoogle Scholar
• Barrows GH, Burton RM, Jarrett DD, et al. Immunochemical detection of human blood in feces. Am J Clin Pathol. 1978;69(3):342–346.
   PubMed Web of Science ®Google Scholar
• Lee JK, Liles EG, Bent S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171.
   PubMed Web of Science ®Google Scholar
• Ribbing Wilén H, Blom J, Höijer J, et al. Fecal immunochemical test in cancer screening – colonoscopy outcome in FIT positives and negatives. Scand. J. Gastroenterol. 2019. 53(3):303–308.
   Google Scholar
• Allison JE, Fraser CG, Halloran SP, et al. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014;8:117–130.
   PubMed Web of Science ®Google Scholar
• Brenner H, Werner S. Selecting a cut-off for colorectal cancer screening with a fecal immunochemical test. Clin Transl Gastroenterol. 2017;8(8):e111.
   PubMedGoogle Scholar
• Brenner H, Haug U, Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol. 2010;105:2457–2464.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;371:187–188.
   PubMed Web of Science ®Google Scholar
• Carlson CM, Kirby KA, Casadei MA, et al. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up? Arch Intern Med. 2011;171(3):249–256.
   PubMedGoogle Scholar
• Fisher DA, Jeffreys A, Coffman CJ, et al. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1232–1235.
   PubMed Web of Science ®Google Scholar
• Saito H. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen. 2006;13(1):S6–S7.
   PubMedGoogle Scholar
• Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59(1):62–68.
   PubMed Web of Science ®Google Scholar
• Segnan N, Senore C, Andreoni B, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132(7):2304–2312.
   PubMed Web of Science ®Google Scholar
• Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012. 366:2345–2357.
   PubMed Web of Science ®Google Scholar
• Elmunzer BJ, Hayward RA, Schoenfeld PS, et al. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9:e1001352.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening test use–United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:881–888.
   PubMed Web of Science ®Google Scholar
• Provenzale D, Gupta S, Ahnen DJ, et al. NCCN guidelines insights: colorectal cancer screening, version 1.2018. J Natl Compr Canc Netw. 2018;16(8):939–949.
   PubMed Web of Science ®Google Scholar
• Kahi CJ, Imperiale TF, Juliar BE, et al. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7(7):770.
   PubMed Web of Science ®Google Scholar
• Manser CN, Bachmann LM, Brunner J, et al. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc. 2012;76(1):110–117.
   PubMed Web of Science ®Google Scholar
• Brenner H, Chang-Claude J, Seiler CM, et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154(1):22–30.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Hassan C, Halligan S, et al. Colorectal cancer: CT colonography and colonoscopy for detection–systematic review and meta-analysis. Radiology. 2011;259:393–405.
   PubMed Web of Science ®Google Scholar
• Baxter NN, Warren JL, Barrett MJ, et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. JCO. 2012;30(21):2664–2669.
   PubMed Web of Science ®Google Scholar
• Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018;67(2):291–298.
   PubMed Web of Science ®Google Scholar
• Vakiani E, Yantiss RK. Pathologic features and biologic importance of colorectal serrated polyps. Adv Anat Pathol. 2009;16(2):79–91.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Kou TD, Rex DK. Complications following colonoscopy with anesthesia assistance: a population-based analysis. JAMA Intern Med. 2013;173(7):551–556.
   PubMed Web of Science ®Google Scholar
• Tran AH, Man Ngor EW, Wu BU. Surveillance colonoscopy in elderly patients: a retrospective cohort study. JAMA Intern Med. 2014;174(10):1675–1682.
   PubMed Web of Science ®Google Scholar
• Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150(12):849–857.
   PubMed Web of Science ®Google Scholar
• Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575–582.
   PubMedGoogle Scholar
• Güneş ED, Örmeci EL, Kunduzcu D. Preventing and diagnosing colorectal cancer with a limited colonoscopy resource. Prod Oper Manag. 2015;24(1). DOI:10.1111/poms.12206.
   Web of Science ®Google Scholar
• Burt RW, Cannon JA, David DS, et al. Colorectal cancer screening. J Natl Compr Canc Netw. 2013;11(12):1538–1575.
   PubMed Web of Science ®Google Scholar
• Dominitz JA, Robertson DJ, Ahnen DJ, et al. Colonoscopy vs. fecal immunochemical test in reducing mortality from colorectal cancer (CONFIRM): rationale for study design. Am J Gastroenterol. 2017;112(11):1736–1746.
   PubMed Web of Science ®Google Scholar
• Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.
   PubMed Web of Science ®Google Scholar
• van Rijn JC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterology. 2006;101(2):343–350.
   PubMed Web of Science ®Google Scholar
• Pickhardt PJ, Nugent PA, Mysliwiec PA, et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med. 2004;141(5):352–359.
   PubMed Web of Science ®Google Scholar
• Rosman AS, Korsten MA. Meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy. Am J Med. 2007;120(3):203–210.e4.
   PubMed Web of Science ®Google Scholar
• Halligan S, Wooldrage K, Dadswell E, et al. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet. 2013;381(9873):1185–1193. 14.
   PubMed Web of Science ®Google Scholar
• Johnson CD, Herman BA, Chen MH, et al. The national CT colonography trial: assessment of accuracy in participants 65 years of age and older. Radiology. 2012;263:401–408.
   PubMed Web of Science ®Google Scholar
• Stoop EM, de Haan MC, de Wijkerslooth TR, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 2012;13(1):55–64.
   PubMed Web of Science ®Google Scholar
• Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA. 2016;315(23):2595–2609.
   PubMed Web of Science ®Google Scholar
• Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250–281.
   PubMed Web of Science ®Google Scholar
• Pyenson B, Pickhardt PJ, Sawhney TG, et al. Medicare cost of colorectal cancer screening: CT colonography vs. optical colonoscopy. Abdom Imaging. 2015;40(8):2966–2976.
   PubMedGoogle Scholar
• Sakamoto T, Mitsuzaki K, Utsunomiya D, et al. Detection of flat colorectal polyps at screening CT colonography in comparison with conventional polypoid lesions. Acta Radiol. 2012;53(7):714–719.
   PubMed Web of Science ®Google Scholar
• IJspeert JE, Tutein Nolthenius CJ, Kuipers EJ, et al. CT-colonography vs. colonoscopy for detection of high-risk sessile serrated polyps. Am J Gastroenterol. 2016;111(4):516–522.
   PubMed Web of Science ®Google Scholar
• Hellström M, Svensson MH, Lasson A. Extracolonic and incidental findings on CT colonography (virtual colonoscopy). AJR Am J Roentgenol. 2004;182(3):631–638.
   PubMed Web of Science ®Google Scholar
• Hara AK, Johnson CD, MacCarty RL, et al. Incidental extracolonic findings at CT colonography. Radiology. 2000;215(2):353–357.
   PubMed Web of Science ®Google Scholar
• Halligan S, Wooldrage K, Dadswell E, et al. Identification of Extracolonic Pathologies by Computed Tomographic Colonography in Colorectal Cancer Symptomatic Patients. Gastroenterology. 2015;149:89–101.
   PubMed Web of Science ®Google Scholar
• Rex DK, Adler SN, Aisenberg J, et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology. 2015;148(5):948–957.e2.
   PubMed Web of Science ®Google Scholar
• Lange CP, Campan M, Hinoue T, et al. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS One. 2012;7(11):e50266.
   PubMed Web of Science ®Google Scholar
• de Wit M, Fijneman RJ, Verheul HM, et al. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. Clin Biochem. 2013;46(6):466–479.
   PubMed Web of Science ®Google Scholar
• Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012;142:246–248.
   Web of Science ®Google Scholar
• Wang JY, Yeh CS, Chen YF, et al. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer. Int J Mol Med. 2006;17:737–747.
   PubMed Web of Science ®Google Scholar
• Carpelan-Holmström M, Louhimo J, Stenman UH, et al. Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology. 2004;66(4):296–302.
   PubMed Web of Science ®Google Scholar
• Carpelan-Holmström M, Louhimo J, Stenman UH, et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002. 22:2311–2316.
   PubMed Web of Science ®Google Scholar
• Leung WK, To KF, Man EP, et al. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterology. 2005;100(10):2274–2279.
   PubMed Web of Science ®Google Scholar
• Wang JY, Hsieh JS, Chang MY, et al. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers. World J Surg. 2004;28:721–726.
   PubMed Web of Science ®Google Scholar
• Silva JM, Rodriguez R, Garcia JM, et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut. 2002;50(4):530–534.
   PubMed Web of Science ®Google Scholar
• Schuster R, Max N, Mann B, et al. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer. 2004;108(2):219–227.
   PubMed Web of Science ®Google Scholar
• Hundt S, Haug U, Brenner H. Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev. 2007;16(10):3519–3953.
   Web of Science ®Google Scholar
• Cordero OJ, Ayude D, Nogueira M, et al. Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer. 2000;83(9):1139–1146.
   PubMed Web of Science ®Google Scholar
• Fedarko NS, Jain A, Karadag A, et al. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res. 2001;7.(12):4060–4066.
   PubMed Web of Science ®Google Scholar
• Soroush AR, Zadeh HM, Moemeni M, et al. Plasma prolactin in patients with colorectal cancer. BMC Cancer. 2004;4(1):97.
   PubMedGoogle Scholar
• Chen YD, Zheng S, Yu JK, et al. Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res. 2004;10(24):8380–8385.
   PubMed Web of Science ®Google Scholar
• Yu JK, Chen YD, Zheng S. An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. WJG. 2004;10(21):3127–3131.
   PubMed Web of Science ®Google Scholar
• Ward DG, Suggett N, Cheng Y, et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer. 2006;94(12):1898–1905.
   PubMed Web of Science ®Google Scholar
• de Noo ME, Mertens BJ, Ozalp A, et al. Detection of colorectal cancer using MALDI-TOF serum protein profiling. Eur J Cancer. 2006;42(8):1068–1076.
   PubMed Web of Science ®Google Scholar
• Bustin SA, Gyselman VG, Williams NS, et al. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer. 1999;79(11-12):1813–1820.
   PubMed Web of Science ®Google Scholar
• Schiedeck TH, Wellm C, Roblick UJ, et al. Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay. Dis Colon Rectum. 2003;46(6):818–825.
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39(16):7223–7233.
   PubMed Web of Science ®Google Scholar
• Hong BS, Cho JH, Kim H, et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics. 2009;10(1):556.
   PubMedGoogle Scholar
• Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA. 2005;102(45):16368–16373.
   PubMed Web of Science ®Google Scholar
• Imaoka H, Toiyama Y, Fujikawa H, et al. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Ann Oncol. 2016;27(10):1879–1886.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li P, Ju H, et al. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23.(12):2783–2792.
   PubMed Web of Science ®Google Scholar
• Fang Z, Tang J, Bai Y, et al. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. J Exp Clin Cancer Res. 2015;34(1):86.
   PubMedGoogle Scholar
• Laird PW. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet. 2010;11(3):191–203.
   PubMed Web of Science ®Google Scholar
• Wallner M, Herbst A, Behrens A, et al. Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res. 2006;12(24):7347–7352.
   PubMed Web of Science ®Google Scholar
• Hall PA, Russell SE. The pathobiology of the septin gene family. J Pathol. 2004;204(4):489–505.
   PubMed Web of Science ®Google Scholar
• deVos T, Tetzner R, Model F, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55(7):1337–1346. 30.
   PubMed Web of Science ®Google Scholar
• Grützmann R, Molnar B, Pilarsky C, et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One. 2008;3(11):e3759.
   PubMed Web of Science ®Google Scholar
• Herbst A, Kolligs FT. Detection of DNA hypermethylation in remote media of patients with colorectal cancer: new biomarkers for colorectal carcinoma. Tumor Biol. 2012;33(2):297–305.
   PubMedGoogle Scholar
• Lofton-Day C, Model F, Devos T, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008;54(2):414–423.
   PubMed Web of Science ®Google Scholar
• Church TR, Wandell M, Lofton-Day C, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut. 2014;63(2):317–325.
   PubMed Web of Science ®Google Scholar
• Summers T, Langan RC, Nissan A, et al. Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection. J Cancer. 2013;4(3):210–216.
   PubMed Web of Science ®Google Scholar
• Li B, Gan A, Chen X, et al. Diagnostic performance of DNA hypermethylation markers in peripheral blood for the detection of colorectal cancer: a meta-analysis and systematic review. PLoS One. 2016;11(5):e0155095.
   PubMed Web of Science ®Google Scholar
• Parikh RB, Prasad V. Blood-based screening for colon cancer: a disruptive innovation or simply a disruption? JAMA. 2016;315(23):2519–2520.
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Alvarez-Osorio L, Rösch T, et al. Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA. EIO. 2014;2:E96–E104.
   Google Scholar
• Altobelli E, Angeletti PM, Latella G. Role of urinary biomarkers in the diagnosis of adenoma and colorectal cancer: a systematic review and meta-analysis. J Cancer. 2016;7(14):1984–2004.
   PubMed Web of Science ®Google Scholar
• Wang H, Tso V, Wong C, et al. Development and validation of a highly sensitive urine-based test to identify patients with colonic adenomatous polyps. Clin Transl Gastroenterol. 2014;5(3):e54.
   PubMed Web of Science ®Google Scholar
• de Meij TG, Larbi IB, van der Schee MP, et al. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study. Int J Cancer. 2014;134(5):1132–1138.
   PubMed Web of Science ®Google Scholar
• Altomare DF, Di Lena M, Porcelli F, et al. Effects of curative colorectal cancer surgery on exhaled volatile organic compounds and potential implications in clinical follow-up. Ann Surg. 2015;262(5):862–867.
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330–339.
   PubMed Web of Science ®Google Scholar
• Yang T, Owen JL, Lightfoot YL, et al. Microbiota impact on the epigenetic regulation of colorectal cancer. Trends Mol Med. 2013;19(12):714–725.
   PubMed Web of Science ®Google Scholar
• von Frieling J, Fink C, Hamm J, et al. Grow with the challenge – microbial effects on epithelial proliferation, carcinogenesis, and cancer therapy. Front Microbiol. 2018;9:2020.
   PubMed Web of Science ®Google Scholar
• Chen J, Domingue JC, Sears CL. Microbiota dysbiosis in select human cancers: evidence of association and causality. Semin Immunol. 2017;32:25–34.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Khilkin M, Kerjaschki D, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology. 1998;115(2):281–286.
   PubMed Web of Science ®Google Scholar
• Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299–306.
   PubMed Web of Science ®Google Scholar
• Zhang S, Cai S, Ma Y. Association between Fusobacterium nucleatum and colorectal cancer: progress and future directions. J Cancer. 2018;9(9):1652–1659.
   PubMed Web of Science ®Google Scholar
• Kohoutova D, Smajs D, Moravkova P, et al. Escherichia colistrains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia. BMC Infect. Dis. 2014;14:733.
   PubMed Web of Science ®Google Scholar
• Wong SH, Kwong TNY, Chow T-C, et al. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut. 2017;66:1441–1448.
   PubMed Web of Science ®Google Scholar
• Guo S, Li L, Xu B, et al. A simple and novel fecal biomarker for colorectal cancer: ratio of Fusobacterium Nucleatum to probiotics populations, based on their antagonistic effect. Clin Chem. 2018;64(9):1327–1337.
   PubMed Web of Science ®Google Scholar
• Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Research Data with Delay Adjustment, Malignant Only, Nov 2016 Sub (1975-2014) <Katrina/Rita Population Adjustment>‐Linked To County Attributes‐Total US, 19. Bethesda, MD; 2017.
   Google Scholar
• Surveillance Epidemiology and End Results (SEER) Program. SEER*Stat Database: Mortality‐All COD, Aggregated With State, Total US (1969‐2014) <Katrina/Rita Population Adjustment> (underlying mortality data provided by the National Vital Statistics System. Bethesda, MD; 2017.
   Google Scholar
• NAACCR Incidence Data‐CiNA Analytic File, 1995‐2014. Public Use (which includes data from CDC’s National Program of Cancer Registries (NPCR), CCCR’s Provincial and Territorial Registries, and the NCI’s Surveillance, Epidemiology and End Results (SEER) Reg. Springfield, IL; 2016.
   Google Scholar
• Peterse EFP, Meester RGS, Siegel RL, et al. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline. Cancer. 2018;124(14):2964–2973.
   PubMed Web of Science ®Google Scholar
• Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12(10):1624–1634.e1.
   PubMed Web of Science ®Google Scholar
• Yang HJ, Choi S, Park SK, et al. Derivation and validation of a risk scoring model to predict advanced colorectal neoplasm in adults of all ages. J Gastroenterol Hepatol. 2017;32(7):1328–1335.
   PubMed Web of Science ®Google Scholar
• Park YM, Kim HS, Park JJ, et al. A simple scoring model for advanced colorectal neoplasm in asymptomatic subjects aged 40–49 years. BMC Gastroenterol. 2017;17:7.
   PubMed Web of Science ®Google Scholar
• Peng L, Weigl K, Boakye D, et al. Risk scores for predicting advanced colorectal neoplasia in the average-risk population: a systematic review and meta-analysis. Am J Gastroenterol. 2018;113(12):1788–1800.
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Monahan PO, Stump TE, et al. derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med. 2015;163(5):339–346.
   PubMed Web of Science ®Google Scholar
• Chiu HM, Ching JY, Wu KC, et al. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology. 2016;150(3):617–625.e3.
   PubMed Web of Science ®Google Scholar
• Hsu L, Jeon J, Brenner H, et al. A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology. 2015;148(7):1330.e14–1339.e14.
   Web of Science ®Google Scholar
• Cai QC, Yu E, Da Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol. 2012;175:(6):584–593.
   PubMed Web of Science ®Google Scholar
• Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg. 2008;95(8):1029–1036.
   PubMed Web of Science ®Google Scholar
• Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. JNCI J Natl. Cancer Inst. 2007;99(19):1462–1470.
   Web of Science ®Google Scholar
• Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality. JAMA. 2014;312(6):606.
   PubMed Web of Science ®Google Scholar
• Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–1633.
   PubMed Web of Science ®Google Scholar
• Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095–1105.
   PubMed Web of Science ®Google Scholar